Download:
pdf |
pdfPrint Date: 5/5/20
Title:
OMB Renew Document of BRFSS Asthma Call-back Survey (ACBS)
Project Id:
0900f3eb81b0af81
Accession #:
NCEH-AST-3/26/20-0af81
Project Contact:
Qin_Xiaoting (csk5)
Organization:
NCEH/ATSDR/DEHSP/ACHB/AST
Status:
Pending Clearance
Intended Use:
Project Determination
Estimated Start Date:
03/26/2020
Estimated Completion Date:
05/06/2020
CDC/ATSDR HRPO/IRB Protocol #:
IRB excempt for BRFSS
OMB Control #:
OMB No. 920-1204
Determinations
Determination
Justification
Completed
Entered By & Role
HSC:
Does NOT Require HRPO
Review
Not Research
5/5/20
Davis_Stephanie I. (sgd8) CIO HSC
5/5/20
Davis_Stephanie I. (sgd8) CIO OMB / PRA
PRA:
PRA Applies
Description & Funding
Description
Priority:
Standard
Date Needed:
05/06/2020
Determination Start Date:
03/26/20
Description:
??This is a revision ICR for the Behavioral Risk Factor Surveillance System (BRFSS) Asthma Call-back Survey (ACBS). ACBS will
produce state- or jurisdiction-level data about asthma. The goal of this information collection is to add in-depth data about those with
asthma (e.g., symptoms, environmental factors, medication use etc.) and their experiences (e.g., activity limitation, health system
use, self-management education, etc.). ACBS in approved under OMB Control No. 0920-1204, expiration date 11/30/2020. CDC is
seeking PRA clearance to revise and to continue to collect state level asthma data for next three-year cycle. This package includes
Supporting Statements A and B, attachments, and other required supporting information. A new proposal has been made to revise
the survey protocol to improve ACBS response. The revisions include three significant changes: 1. To recommend the ACBS
interview be done within two days of the BRFSS interview, instead of two weeks; 2. Instead of identifying the most knowledge
person at beginning of ACBS, to identify the most knowledge person at the end of BRFSS, record it in the state-added questions
section, and not record it in the public release data; and 3. If both the randomly selected child and adult responding to the BRFSS
have a diagnosis of asthma, increasing the child proportion from 75% up to 100% in order to maximize child sample size.
IMS/CIO/Epi-Aid/Chemical Exposure Submission:
No
IMS Activation Name:
Not selected
CIO Emergency Response Name:
Not selected
Epi-Aid Name:
Not selected
Assessment of Chemical Exposure Name:
Not selected
Goals/Purpose
CDC is requesting a three-year Paperwork Reduction Act (PRA) clearance to revise and to continue to collect information under the
Behavioral Risk Factor Surveillance System (BRFSS) Asthma Call-back Survey (ACBS) (OMB Control No. 0920-1204, expiration
date 11/30/2020)
Objective:
Current ACBS OMB number: 920-1204, expired at 11/30/2020. CDC is seeking PRA clearance to continue to collect state level
asthma data for next three year cycle.
Activities or Tasks:
New Collection of Information, Data, or Biospecimens
Target Populations to be Included/Represented:
General US Population
Tags/Keywords:
Surveys and Questionnaires
CDC's Role:
Activity originated and designed by CDC staff, or conducted at the specific request of CDC, or CDC staff will approve study design
and data collection as a condition of any funding provided
Method Categories:
Survey
Data will be collected through a follow-up survey approximately two days after the Behavioral Risk Factor Surveillance System
Methods:
(BRFSS) survey is administered. The ACBS is an ongoing data collection administered, on behalf of NCEH, by CDC#s National
Center for Chronic Disease Prevention and Health Promotion (NCCDPHP) through their BRFSS cooperative agreement under CDCRFA DP15-1513 (BRFSS, OMB Control No. 0920-1061, expiration date 3/31/2021). The ACBS is an in-depth asthma survey that
contains questions on asthma such as medication use, symptoms, health care use, and disease management. The respondent will
be either an adult (BRFSS respondent) or child (chosen using the Random Child Selection and Childhood Asthma Prevalence
module) who has ever had asthma. The ACBS sample includes all cases meeting the qualification criteria in BRFSS. ACBS will only
conduct one call-back interview per household. In order for a state to include children in the ACBS, it must have the Random Child
Selection and Childhood Asthma Prevalence modules in the BRFSS. If a randomly selected child with response on the BRFSS has
a diagnosis of asthma, then he/she is eligible for the ACBS. If both the randomly selected child and adult responding to the BRFSS
have a diagnosis of asthma, then one is eligible for the ACBS through a 75/25 split. NCEH/DEHSP/ACHB funds Behavioral Risk
Factors Surveillance System (BRFSS) for Asthma-Call-back Survey (ACBS) annually. The BRFSS provides funding to each
recipients/jurisdictions using cooperative agreement for them to conduct ACBS in their jurisdiction. Each recipient/jurisdiction has
their own methods of collecting data, whether to use contractor or not.
Collection of Info, Data or Biospecimen:
1. CDC annually provides the ACBS questionnaire and compiles requests regarding the questionnaire modifications from states and
sends the requests to the questionnaire work group. This work group is comprised of state epidemiologists and CDC Health
Scientists, who review and vote on proposed changes and new questions. Questionnaire revisions are described in the supporting
documents part A1. All states use the same ACBS questionnaire. CDC also produces data processing layouts. 2. Information
collection is conducted by telephone interview. CDC provides Computer-Assisted Telephone Interviewing (CATI) programming to
states for their use. States may also opt to use their own CATI programming software. 3. ACBS awardees are responsible for field
operations and to determine how their data will be collected within the BRFSS and ACBS guidelines. States may collect data using
in-house calling centers, hire vendors using RFP procedures, or contract with universities. The data collector is the same for BRFSS
and ACBS. Data collectors must develop and maintain procedures to ensure respondents# privacy, assure and document the
quality of the interviewing process, and supervise and monitor the interviewers. Files containing phone numbers must be maintained
separately from any files containing responses. 4. States submit de-identified data files to CDC on a monthly or quarterly basis for
cleaning and weighting. CDC returns clean, weighted data files to the state of origin for its use. Through the BRFSS ACBS website,
CDC also makes cleaned subsets of state data files available for public use, along with information about the source of sample
(landline or cell phone), weighting, and any restrictions on publication or use of the data (https://www.cdc.gov/brfss/acbs/index.htm).
Expected Use of Findings/Results:
CDC National Asthma Control Program (NACP) uses BRFSS ACBS data to plan for and evaluate public health programs at the
(sub) state level. Information collected will be used by asthma control programs located in state health departments and at the
federal level to improve tracking the disease, and for planning and evaluating interventions to reduce the disease burden. For most
states, ACBS data is the only source of asthma related health information that is targeted to state asthma prevention and
intervention and needs.
Could Individuals potentially be identified based on
Information Collected?
Yes
Will PII be captured (including coded data)?
Yes
Does CDC have access to the identifiers?
No
Is an assurance of confidentiality in place or
planned?
No
Is a certificate of confidentiality in place or planned? No
Is there a formal written agreement prohibiting the
release of identifiers?
No
Funding
Funding Type
Funding Title
CDC Cooperative Agreement
CDC-RFA DP15-1513
Funding #
Original Budget Yr
# Years Award
Review Attributes
Public Health Surveillance
Regulation and Policy
Do you anticipate this project will be submitted to
the IRB office
No
Estimated number of study participants
Population - Children
N/A
Population - Minors
N/A
Population - Prisoners
N/A
Population - Pregnant Women
N/A
Population - Emancipated Minors
N/A
Suggested level of risk to subjects Do you anticipate this project will be exempt research or non-exempt research
Requested consent process waviers
Informed consent for adults
No Selection
Children capable of providing assent
No Selection
Parental permission
No Selection
Alteration of authorization under HIPPA Privacy
Rule
No Selection
Requested documents of informed consent
Informed consent for adults
No Selection
Children capable of providing assent
No Selection
Parental permission
No Selection
Consent process shown in an understandable language
Reading level has been estimated
No Selection
Comprehension tool is provided
No Selection
Short form is provided
No Selection
Translation planned or performed
No Selection
Certified translation / translator
No Selection
Translation and back-translation to/from target
language(s)
No Selection
Other method
No Selection
Clinical Trial
Involves human participants
No Selection
Assigned to an intervention
No Selection
Evaluate the effect of the intervention
No Selection
Evaluation of a health related biomedical or
behavioral outcome
No Selection
Registerable clinical trial
No Selection
Other Considerations
Exception is requested to PHS informing those
bested about HIV serostatus
No Selection
Human genetic testing is planned now or in the
future
No Selection
Involves long-term storage of identfiable biological
No Selection
specimens
Involves a drug, biologic, or device
No Selection
Conducted under an Investigational New Drug
exemption or Investigational Device Exemption
No Selection
Institutions & Staff
Institutions
Institutions yet to be added .....
Staff
Staff
Member
SIQT Exp.
Date
CITI Biomedical
Exp. Date
Hatice
Zahran
10/25/2021
11/28/2021
Xiaoting
Qin
12/12/2021
CITI Social & Behavioral
Exp. Date
09/14/2019
CITI Good Clinical
Practice Exp. Date
Staff Role
Email
Phone
Organization
Principal
Investigator
hbz4@cdc.
gov
770-4881509
ASTHMA AND COMMUNITY
HEALTH BRANCH
Principal
Investigator
csk5@cdc.
gov
770-4880797
ASTHMA SURVEILLANCE TEAM
Data
DMP
Proposed Data Collection Start Date:
1/1/21
Proposed Data Collection End Date:
4/1/24
Proposed Public Access Level:
Public
Public Access Justification:
States submit de-identified data files to CDC on a monthly or quarterly basis for cleaning and weighting. CDC returns clean,
weighted data files to the state of origin for its use. Through the BRFSS ACBS website, CDC also makes cleaned subsets of state
data files available for public use, along with information about the source of sample (landline or cell phone), weighting, and any
restrictions on publication or use of the data (https://www.cdc.gov/brfss/acbs/index.htm).
ACBS sample files from BRFSS asthma eligible respondents, include phone numbers only. Since sample files are separate from
datasets, no phone numbers are included in the datasets. No dates of birth, last names, or email address are obtained. Information
that details race/ethnicity, occupation and small geographic residence (such as county or zip code) is transferred from BRFFS and
suppressed in the public use dataset based on BRFSS protocol. In order to determine which variables to suppress, the BRFSS
ACBS uses the HHS Safe Harbor guidelines (https://www.hhs.gov/hipaa/for-professionals/privacy/special-topics/de-identification
/index.html).
How Access Will Be Provided for Data:
Plans for Archival and Long Term Preservation:
Spatiality
Spatiality (Geographic Locations) yet to be added .....
Dataset
Dataset Title
Dataset yet to be
added...
Data Publisher
/Owner
Public Access
Level
Public Access
Justification
External Access
URL
Download
URL
Type of Data
Released
Collection Start
Date
Collection End
Date
File Type | application/pdf |
File Modified | 0000-00-00 |
File Created | 2020-05-05 |